Boule Diagnostics AB

Boule Diagnostics AB, founded in 1992, specializes in hematology diagnostics, developing, manufacturing, and distributing automated blood cell counting systems for non-institutional healthcare settings. With a strong focus on accuracy, reliability, and ease of use, Boule has become a key player in providing hematology solutions that support point-of-care testing, outpatient clinics, and decentralized healthcare facilities.

Complete Blood Count (CBC) Systems

A Complete Blood Count (CBC) is one of the most frequently ordered laboratory tests, providing essential insights into anemia, infections, immune system disorders, and hematologic diseases. Boule Diagnostics designs compact, fully automated analyzers that deliver fast and accurate blood cell counts, making them ideal for primary care clinics, diagnostic laboratories, and mobile health services. These systems allow healthcare providers to perform on-site blood analysis, reducing turnaround time and improving patient care.

Simplified Hematology Testing for Decentralized Healthcare

Unlike large hospital laboratories, smaller clinics and non-institutional healthcare settings require user-friendly, cost-effective solutions that do not compromise accuracy. Boule’s hematology analyzers are designed with minimal sample preparation, small reagent volumes, and intuitive operation, allowing medical staff to obtain critical blood count results quickly and efficiently.

Reliable Manufacturing and Quality Control

Boule Diagnostics controls the entire production process, from developing reagents to manufacturing its hematology analyzers, ensuring strict quality control and compliance with international regulatory standards. These systems are engineered to provide consistent, reproducible results, making them a trusted choice for healthcare providers managing chronic conditions, infections, and routine blood screening.